They found no evidence of any other drug playing a role In their 2022 paper on the “Causality Debate,” Suhas in the emergence of sufferers’ schizophrenia, no evidence of Ganesh and Deepak Cyril D’Souza found that “much of the prior mental illness, “no major difference” in heredity — available evidence supports the criteria of strength, con- and a more abrupt onset of schizophrenia symptoms in can-. [...] So If high-potency cannabis were unavailable, researchers far, however, much of the evidence about cannabis use and calculated, 12% of cases of first-episode psychosis could schizophrenia does point in the direction of causality.33 have been prevented across the 12 cities they studied, or 30% Potency as related to o f c a s es in London and 50% of cases in Amsterdam. [...] That the incidence varies across different places is known.47 Di Forti and colleagues, cited earlier, showed48leagues45 that the incidence of schizophrenia doubled in the southeast London between 1965 and 1997 and that of every- variation in the use of high-potency cannabis and in the daily one born in British Columbia from 1975 to 1985 — about use of the drug across 17 different cities in Europe. [...] sible to establish a treatment criteri- on since the studies have no stand- improvements in the As pain researcher Elon Eisenberg ardization regarding the variety and and colleagues put it in a 2022 placebo group was part of the plant that is used, route commentary,132 proof of medical of administration and doses.” moderate to high and cannabis’ efficacy against pain “remains elusive,” and the man. [...] McIlheran is part of a team at the Badger Institute with On the whole varying and sometimes conflicting personal perspectives and affiliations working together to review existing aca- Most of the research published on health effects of canna- demic literature on the ramifications of marijuana legali- bis and presented here do not frame those results in terms of zation in other states.
Authors
- Pages
- 26
- Published in
- United States of America
Table of Contents
- Introduction 2
- A few words about scope 2
- Recreational use in all states where it has been legalized is 2
- Principal findings 3
- CANNABIS REAL FACTS 3
- There is evidence of an association between cannabis and 3
- Usage rates and why they matter 3
- On nomenclature 3
- Health impacts 4
- Psychosis and schizophrenia 4
- Psychosis 4
- Schizophrenia 4
- CANNABIS REAL FACTS 4
- CANNABIS REAL FACTS 5
- Potency as related to 6
- Researchers have linked the frequent use of high-potency 6
- CANNABIS REAL FACTS 6
- Prevalence of schizophrenia 7
- CANNABIS REAL FACTS 7
- Cannabis and depression 8
- The findings lend support to the notion 8
- A 2015 study by Daniel Feingold and colleagues did not 8
- Cannabis and 8
- Research in 2021 by Lena Kristin Wendel and colleagues 8
- CANNABIS REAL FACTS 8
- Cannabis use 8
- CANNABIS REAL FACTS 9
- Prenatal exposure 9
- CANNABIS REAL FACTS 10
- Other general health risks 10
- Hospital care 10
- Pediatric care 10
- Despite multiple public health interventions in legislation 10
- CANNABIS REAL FACTS 11
- Hyperemesis 11
- The affliction is not a small matter. These patients com- 11
- Cardiovascular health 11
- CANNABIS REAL FACTS 12
- Lungs lung cancer and other cancer 12
- CANNABIS REAL FACTS 13
- Medicinal use 13
- Is it efficacious 13
- CANNABIS REAL FACTS 14
- In a 2021 paper billed as the first randomized placebo- 14
- CANNABIS REAL FACTS 15
- The FDA determination 15
- The size of the 15
- CANNABIS REAL FACTS 16
- On the whole 16
- About the author 16
- About this project 16
- CANNABIS REAL FACTS 17
- CANNABIS REAL FACTS 18
- CANNABIS REAL FACTS 19
- CANNABIS REAL FACTS 20
- CANNABIS REAL FACTS 21
- CANNABIS REAL FACTS 22
- CANNABIS REAL FACTS 23
- CANNABIS REAL FACTS 24
- CANNABIS REAL FACTS 25
- CANNABIS REAL FACTS 26
